Resources

Amyloidosis Support Network. (Updated 2003). What is amyloidosis? Retrieved June 2, 2003, from
amyloidosis.org.

Amyloidosis Support Network. (Updated 2003). Overview of primary systemic AL amyloidosis. Retrieved June 3, 2003, from
amyloidosis.org/alsummary.asp.

Beers, M. H., & Berkow, R. (ed). (1999). Amyloidosis [electronic version], The Merck Manual of Diagnosis and Therapy, 17th Edition. Merck Research Laboratories, NJ, 1999.
Retrieved June 2, 2003, from
www.merck.com/pubs/mmanual/section2/chapter18/18a.htm.

Beers, M. H., & Berkow, R., eds. (2003). Familial Mediterranean fever [electronic version], The Merck Manual of Diagnosis and Therapy, 17th Edition. Merck Research Laboratories, NJ, 1999. Retrieved June 2, 200,3 from www.merck.com/pubs/mmanual/section21/chapter289/289a.htm.

ClinicalTrials.gov. (updated 2003). Dexamethasone plus interferon alfa in treating patients with primary systemic amyloidosis. Retrieved June 3, 2003, from www.clinicaltrials.gov/ct/gui/show/NCT00002849?order=23.

Diabetes Research Laboratories. (updated 1999). Islet amyloid polypeptide (IAPP). Retrieved June 3, 2003, from
www.drl.ox.ac.uk/amyloid.html.

Disability Online. (updated 2002). Amyloidosis. Retrieved June 3, 2003, from
www.disability.vic.gov.au/dsonline/dsarticles.nsf/pages/Amyloidosi s?opendocument.

Fauci, A., Braunwald, E., Isselbacher, K., Wilson, J., Martin, J., Kasper, D., Hauser, S., Longo, D., eds. (1998). Harrison's Principles of Internal Medicine, 14th Edition. McGraw-Hill, NY, 1998.

Jaturi, J. & Husseun, M. (updated 2002). Light-chain deposition disease. Retrieved June 2, 2003, from
www.emedicine.com/med/topic1300.htm.

Mayo Foundation for Medical Education and Research. (2002). Amyloidosis. Retrieved June 2, 2003, from
mayoclinic.com/invoke.cfm?id=DS00431.

Mayo Foundation for Medical Education and Research. (2002). Amyloidosis: Causes. Retrieved June 2, 2003, from
www.mayoclinic.com/invoke.cfm?objectid=951A673E-F094-4A0E-B7 93BA81C9BE90FC&section=3.

Mayo Foundation for Medical Education and Research. (nd). Monoclonal gammopathy of undetermined significance: Disease characteristics. Retrieved June 2, 2003, from
www.mayoclinic.org/monoclonalgammopathy-rst/characteristics.ht ml.

Mayo Foundation for Medical Education and Research. (2002). Amyloidosis: Treatment. Retrieved June 3, 2003, from
www.mayoclinic.com/invoke.cfm?objectid=951A673E-F094-4A0E-B7 93BA81C9BE90FC&section=8.

National Institute of Neurological Disorders and Stroke. (Updated 2001). NINDS Creutzfeldt-Jakob Disease information page. Retrieved June 2, 2003, from
www.ninds.nih.gov/health_and_medical/disorders/cjd.htm.

National Library of Medicine & National Institutes of Health. (updated 2002). Alzheimer's disease. Retrieved June 3, 2003, from
www.nlm.nih.gov/medlineplus/ency/article/000760.htm.

Penn State Milton S. Hershey Medical Center. (Updated 2003). Amyloidosis. Retrieved June 3, 2003, from
www.hmc.psu.edu/healthinfo/a/amyloidosis.htm.

Schneider, A., & Szanto, P. (2002). Pathology, 2nd Edition. Philadelphia: Lippincott Williams & Wilkins, 2002.

University of Arizona. (2000). Antibody structure. Retrieved June 2, 2003, from
www.biology.arizona.edu/immunology/tutorials/antibody/structure. html.